Unveiling an Overlooked Link-Promising Drug Efficacy in Lowering Withdrawal Rates in Cancer Trials-Reply

JAMA Oncol. 2024 Mar 1;10(3):411. doi: 10.1001/jamaoncol.2023.6437.

Authors

Shauna L Hillman¹, Aminah Jatoi^{2

3}, Sumithra J Mandrekar¹

Affiliations

¹ Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota.
² Department of Oncology, Mayo Clinic, Rochester, Minnesota.
³ Mayo Foundation for Medical Education and Research, Mayo Clinic, Rochester, Minnesota.

PMID: 38236585
DOI: 10.1001/jamaoncol.2023.6437

No abstract available

Publication types

Letter

MeSH terms

Clinical Trials as Topic
Humans
Neoplasms* / drug therapy
Patient Dropouts